[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"RespirAI US Inc\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":37},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":22,"conditions":23,"keywords":4,"overallStatus":25,"whyStopped":4,"lastUpdateSubmitDate":26,"lastUpdatePostDateStruct":27,"startDateStruct":30,"completionDateStruct":32,"leadSponsor":34,"locationsCount":5},"100635566","early-detection-of-copd-exacerbations-using-home-monitoring-device-100635566",false,"NCT07554352","Early Detection of COPD Exacerbations Using Home Monitoring Device","A Multi-center, Observational Prospective Clinical Study to Evaluate the Safety and Effectiveness of a Home - Monitoring COPD Management Software for Early Detection of Exacerbations.","Inclusion Criteria:\n\n* Age \\>21 years.\n* Physician-diagnosed COPD at least 6 months prior to screening visit.\n* Two or more moderate COPD exacerbations in the past 6 months or 1 severe exacerbation during the past 6 months.\n* Free of exacerbation for 1 month before enrollment.\n\nExclusion Criteria:\n\n* Unable or willing to sign an informed consent.\n* Unable to complete the 6-minute walk test due to physical or mental health conditions.\n* Patients with cardiac pacemaker, defibrillators, or other implanted electronic devices.\n* Pregnancy\n* Study clinician determines that the patient is unable or unwilling to comply with all study procedures.","ALL","21 Years",{"count":19,"type":20},30,"ESTIMATED","OBSERVATIONAL","The goal of this observational study is to evaluate the safety and effectiveness of a home-monitoring device (RespirAI) in the early detection of COPD exacerbations in adults (age \\>21) with physician-diagnosed COPD who are at high risk for exacerbations. The study will collect data from participants with COPD that will be analyzed using an AI-based algorithm to predict exacerbation events. The device's predictions will then be compared against clinically documented exacerbations to assess detection accuracy.",[24],"COPD Exacerbation","NOT_YET_RECRUITING","2026-04-21",{"date":28,"type":29},"2026-04-28","ACTUAL",{"date":31,"type":20},"2026-05",{"date":33,"type":20},"2027-05",{"name":35,"class":36},"RespirAI US Inc","INDUSTRY",""]